Lihang Yao

1.2k total citations
24 papers, 843 citations indexed

About

Lihang Yao is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Lihang Yao has authored 24 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Lihang Yao's work include Cholesterol and Lipid Metabolism (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Cellular transport and secretion (5 papers). Lihang Yao is often cited by papers focused on Cholesterol and Lipid Metabolism (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Cellular transport and secretion (5 papers). Lihang Yao collaborates with scholars based in United States, Canada and Italy. Lihang Yao's co-authors include John J. Renger, Nathan G. Hatcher, Robert E. Drolet, Laura A. Woollett, Joel B. Schachter, Marija Usenovic, Sophie Parmentier‐Batteur, Renee C. Gaspar, Sean M. Smith and Norman A. Granholm and has published in prestigious journals such as Journal of Neuroscience, Gastroenterology and Scientific Reports.

In The Last Decade

Lihang Yao

23 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lihang Yao United States	16	340	228	169	118	109	24	843
Yuan‐Jian Yang China	21	548 1.6×	267 1.2×	341 2.0×	123 1.0×	33 0.3×	51	1.4k
Elisabetta Lauretti United States	18	523 1.5×	585 2.6×	205 1.2×	45 0.4×	94 0.9×	26	1.3k
Setsuko Kanai Japan	21	283 0.8×	230 1.0×	291 1.7×	56 0.5×	53 0.5×	61	1.2k
Esther Parada Spain	21	791 2.3×	224 1.0×	244 1.4×	46 0.4×	77 0.7×	26	1.6k
Jeffrey W. Cramer United States	14	450 1.3×	639 2.8×	346 2.0×	60 0.5×	54 0.5×	20	1.3k
Wei-Yi Ong Singapore	17	245 0.7×	225 1.0×	274 1.6×	64 0.5×	110 1.0×	21	935
Ana M. Martín‐Moreno Spain	12	383 1.1×	224 1.0×	418 2.5×	155 1.3×	75 0.7×	12	1.3k
Rosa Maria A. Simmons United States	15	359 1.1×	421 1.8×	518 3.1×	84 0.7×	59 0.5×	21	1.0k
Yvonne Bouter Germany	18	319 0.9×	727 3.2×	297 1.8×	77 0.7×	59 0.5×	38	1.2k
Oriol Busquets Spain	17	284 0.8×	389 1.7×	165 1.0×	39 0.3×	34 0.3×	31	888

Countries citing papers authored by Lihang Yao

Since Specialization

Citations

This map shows the geographic impact of Lihang Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihang Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihang Yao more than expected).

Fields of papers citing papers by Lihang Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihang Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihang Yao. The network helps show where Lihang Yao may publish in the future.

Co-authorship network of co-authors of Lihang Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Lihang Yao. A scholar is included among the top collaborators of Lihang Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihang Yao. Lihang Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yao, Lihang, et al.. (2025). Deficiency in NPC2 results in disruption of mitochondria-late endosome/lysosomes contact sites and endo-lysosomal lipid dyshomeostasis. Scientific Reports. 15(1). 325–325.

Leyns, Cheryl E. G., Alice Prigent, Lihang Yao, et al.. (2023). Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson’s disease. npj Parkinson s Disease. 9(1). 74–74. 18 indexed citations

Kandebo, Monika, Lihang Yao, Bang-Lin Wan, et al.. (2022). Neuronopathic GBA1L444P Mutation Accelerates Glucosylsphingosine Levels and Formation of Hippocampal Alpha-Synuclein Inclusions. Journal of Neuroscience. 43(3). 501–521. 22 indexed citations

Jinn, Sarah, Lihang Yao, Monika Kandebo, et al.. (2021). A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy. Neurobiology of Disease. 159. 105507–105507. 14 indexed citations

Hatcher, Nathan G., et al.. (2020). High-defined quantitative snapshots of the ganglioside lipidome using high resolution ion mobility SLIM assisted shotgun lipidomics. Analytica Chimica Acta. 1146. 77–87. 36 indexed citations

Rocha, Emily M., Briana R. De Miranda, Sandra L. Castro, et al.. (2019). LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease. Neurobiology of Disease. 134. 104626–104626. 61 indexed citations

Yao, Lihang, Andres D. Ramirez, Anthony J. Roecker, et al.. (2017). The dual orexin receptor antagonist, DORA‐22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine. Journal of Neurochemistry. 142(2). 204–214. 7 indexed citations

Zhao, Zhijian, Scott T. Harrison, John M. Sanders, et al.. (2016). Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(12). 2952–2956. 10 indexed citations

Usenovic, Marija, Robert E. Drolet, Lihang Yao, et al.. (2015). Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells. Journal of Neuroscience. 35(42). 14234–14250. 179 indexed citations

10.

Gotter, Anthony L., Susan L. Garson, Joanne Stevens, et al.. (2014). Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators. BMC Neuroscience. 15(1). 109–109. 40 indexed citations

11.

Ramirez, Andres D., Anthony L. Gotter, Steven V. Fox, et al.. (2013). Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators. Frontiers in Neuroscience. 7. 254–254. 33 indexed citations

12.

Fox, Steven V., Anthony L. Gotter, Spencer J. Tye, et al.. (2013). Quantitative Electroencephalography Within Sleep/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats. Neuropsychopharmacology. 38(12). 2401–2408. 33 indexed citations

13.

Smith, Sean M., Jason M. Uslaner, Christopher D. Cox, et al.. (2012). The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey. Neuropharmacology. 64. 215–223. 70 indexed citations

14.

Uslaner, Jason M., Sean M. Smith, Sarah L. Huszar, et al.. (2010). T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats. Neuropharmacology. 62(3). 1413–1421. 27 indexed citations

15.

Smith, Sean M., Jason M. Uslaner, Lihang Yao, et al.. (2008). The Behavioral and Neurochemical Effects of a Novel d-Amino Acid Oxidase Inhibitor Compound 8 [4 H-Thieno [3,2-b]pyrrole-5-carboxylic Acid] and d-Serine. Journal of Pharmacology and Experimental Therapeutics. 328(3). 921–930. 73 indexed citations

16.

Yao, Lihang, et al.. (2007). Inability to fully suppress sterol synthesis rates with exogenous sterol in embryonic and extraembyronic fetal tissues. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1771(11). 1372–1379. 15 indexed citations

17.

Wang, Yanwen, Peter J.H. Jones, Laura A. Woollett, et al.. (2006). Effects of chenodeoxycholic acid and deoxycholic acid on cholesterol absorption and metabolism in humans. Translational research. 148(1). 37–45. 34 indexed citations

18.

Woollett, Laura A., Lihang Yao, Peter J.H. Jones, et al.. (2004). Cholic acid supplementation enhances cholesterol absorption in humans. Gastroenterology. 126(3). 724–731. 47 indexed citations

19.

Woollett, Laura A., Lihang Yao, Peter J.H. Jones, et al.. (2003). Effect of ursodeoxycholic acid on cholesterol absorption and metabolism in humans. Journal of Lipid Research. 44(5). 935–942. 30 indexed citations

20.

Yao, Lihang, Yuexia Liang, Walter S. Trahanovsky, Robert E. Serfass, & Wendy S. White. (2000). Use of a ¹³C tracer to quantify the plasma appearance of a physiological dose of lutein in humans. Lipids. 35(3). 339–348. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact